Starling Oncology STLN
NASDAQ STLN
$6.83 +0.20 (+3.02%)
At close: Oct 21, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Long-Term Debt Issuances (2020)

Updated

Starling Oncology's Long-Term Debt Issuances was $110 million in FY2022.

Analysis

Starling Oncology (STLN) Long-Term Debt Issuances (2020) Analysis & Trends

  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $12.49 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 HCA Healthcare 101.22 Bn 97.23 Bn - 2.99 Bn
2 Natera 59.29 Bn 54.98 Bn 485.19 Mn -
3 Quest Diagnostics 26.56 Bn 24.69 Bn 1.03 Bn 494.00 Mn
4 Labcorp Holdings 26.41 Bn 24.16 Bn 1.11 Bn 175.00 Mn
5 Tenet Healthcare 22.49 Bn 11.49 Bn - 14.00 Mn
6 Guardant Health 22.12 Bn 18.19 Bn 219.03 Mn -
7 BrightSpring Health Services 12.91 Bn 11.24 Bn 492.75 Mn -
8 Fresenius Medical Care AG 12.56 Bn 4.51 Bn 1.52 Bn 121.81 Mn
9 Tempus AI 12.17 Bn 9.20 Bn 246.50 Mn 443.13 Mn
10 Starling Oncology 701.64 Mn 569.05 Mn 27.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 12.29 Mn
Mar 31, 2020 200,000.00
API Access

Starling Oncology Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=STLN&period=max&api_key=YOUR_API_KEY